Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trialAnthony C. Nichols, David A. Palma, Michael Hier et al.|The Lancet Oncology|2019Cited by 459
Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy for Patients With Head and Neck CancerAlona Zer, Lori J. Bernstein, Gregory R. Pond et al.|JAMA Otolaryngology–Head & Neck Surgery|2017Cited by 56
Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization studyAbhinav Thakral, Osvaldo Espin‐Garcia, Jong Wook Lee et al.|Nature Communications|2024Cited by 42
Wearable Technologies in Head and Neck Oncology: Scoping ReviewMatthew Shammas‐Toma, Christopher M. K. L. Yao, Gianluca Sampieri et al.|JMIR mhealth and uhealth|2025Cited by 4
Abstract 7399: Polygenic risk score-based smoking and drinking behaviors and head and neck squamous cell cancer risk by HPV statusTianzhichao Hou, Geoffrey Liu, Abhinav Thakral et al.|Cancer Research|2025Cited by 0